{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:12:46Z","timestamp":1792098766732,"version":"4.4.0"},"reference-count":97,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Metabolic-dysfunction-associated fatty liver disease (MAFLD) is the recent nomenclature designation that associates the condition of non-alcoholic fatty liver disease (NAFLD) with metabolic dysfunction. Its diagnosis has been debated in the recent period and is generally associated with a diagnosis of steatosis and at least one pathologic condition among overweight\/obesity, type 2 diabetes mellitus, and metabolic dysregulation. Its pathogenesis is defined by a \u201cmultiple-hit\u201d model and is associated with alteration or dysbiosis of the gut microbiota. The pathogenic role of dysbiosis of the gut microbiota has been investigated in many diseases, including obesity, type 2 diabetes mellitus, and NAFLD. However, only a few works correlate it with MAFLD, although common pathogenetic links to these diseases are suspected. This review underlines the most recurrent changes in the gut microbiota of patients with MAFLD, while also evidencing possible pathogenetic links.<\/jats:p>","DOI":"10.3390\/medicina59030594","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T03:33:57Z","timestamp":1679024037000},"page":"594","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome"],"prefix":"10.3390","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5922-1524","authenticated-orcid":false,"given":"Ludovico","family":"Abenavoli","sequence":"first","affiliation":[{"name":"Department of Health Sciences, University \u201cMagna Graecia\u201d, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7084-8264","authenticated-orcid":false,"given":"Giuseppe Guido Maria","family":"Scarlata","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University \u201cMagna Graecia\u201d, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2101-1118","authenticated-orcid":false,"given":"Emidio","family":"Scarpellini","sequence":"additional","affiliation":[{"name":"Translationeel Onderzoek van Gastro-enterologische Aandoeningen (T.A.R.G.I.D.), Gasthuisberg University Hospital, KU Leuven, Herestraat 49, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2017-4270","authenticated-orcid":false,"given":"Luigi","family":"Boccuto","sequence":"additional","affiliation":[{"name":"School of Nursing, Healthcare Genetics Program, Clemson University, Clemson, SC 29634, USA"},{"name":"School of Health Research, Clemson University, Clemson, SC 29634, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0871-4644","authenticated-orcid":false,"given":"Rocco","family":"Spagnuolo","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University \u201cMagna Graecia\u201d, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6196-9358","authenticated-orcid":false,"given":"Bruno","family":"Tilocca","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University \u201cMagna Graecia\u201d, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0114-5872","authenticated-orcid":false,"given":"Paola","family":"Roncada","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University \u201cMagna Graecia\u201d, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5120-1046","authenticated-orcid":false,"given":"Francesco","family":"Luzza","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University \u201cMagna Graecia\u201d, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1111\/liv.14620","article-title":"MAFLD vs. NAFLD: Let the contest begin!","volume":"40","author":"Bianco","year":"2020","journal-title":"Liver Int."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1111\/liv.14548","article-title":"Comparison of MAFLD and NAFLD diagnostic criteria in real world","volume":"40","author":"Lin","year":"2020","journal-title":"Liver Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1111\/liv.14675","article-title":"MAFLD identifies patients with significant hepatic fibrosis better than NAFLD","volume":"40","author":"Yamamura","year":"2020","journal-title":"Liver Int."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/hep.32131","article-title":"Metabolic dysfunction-associated fatty liver disease improves detection of high liver stiffness: The Rotterdam Study","volume":"75","author":"Ayada","year":"2022","journal-title":"Hepatology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/hepr.13685","article-title":"MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: Generalized estimating equation approach","volume":"5","author":"Tsutsumi","year":"2021","journal-title":"Hepatol. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S2468-1253(22)00062-0","article-title":"Global multi-stakeholder endorsement of the MAFLD definition","volume":"7","author":"Bugianesi","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/liv.14828","article-title":"Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population","volume":"41","author":"Ciardullo","year":"2021","journal-title":"Liver Int."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Chen, Y.L., Li, H., Li, S., Xu, Z., Tian, S., Wu, J., Liang, X.Y., Li, X., Liu, Z.L., and Xiao, J. (2021). Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: A cross-sectional comparative study. BMC Gastroenterol., 21.","DOI":"10.1186\/s12876-021-01782-w"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Yuan, Q., Wang, H., Gao, P., Chen, W., Lv, M., Bai, S., and Wu, J. (2022). Prevalence and Risk Factors of Metabolic-Associated Fatty Liver Disease among 73,566 Individuals in Beijing, China. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19042096"},{"key":"ref_11","first-page":"406","article-title":"Increased risk of MAFLD and Liver Fibrosis in Inflammatory Bowel Disease Independent of Classic Metabolic Risk Factors","volume":"21","author":"Calleja","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/j.cgh.2021.02.030","article-title":"Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Adults","volume":"20","author":"Liu","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Hrncir, T., Hrncirova, L., Kverka, M., Hromadka, R., Machova, V., Trckova, E., Kostovcikova, K., Kralickova, P., Krejsek, J., and Tlaskalova-Hogenova, H. (2021). Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions. Microorganisms, 9.","DOI":"10.3390\/microorganisms9050957"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"8787","DOI":"10.3748\/wjg.v21.i29.8787","article-title":"Role of the normal gut microbiota","volume":"21","author":"Jandhyala","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12934-022-01769-6","article-title":"Assess the diversity of gut microbiota among healthy adults for forensic application","volume":"21","author":"Wang","year":"2022","journal-title":"Microb. Cell Factories"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Rinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Miggiano, G.A.D., Gasbarrini, A., and Mele, M.C. (2019). What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms, 7.","DOI":"10.3390\/microorganisms7010014"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00109-016-1492-2","article-title":"Microbiome and metabolic disease: Revisiting the bacterial phylum Bacteroidetes","volume":"95","author":"Johnson","year":"2017","journal-title":"J. Mol. Med."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Mariat, D., Firmesse, O., Levenez, F., Guimar\u0103es, V., Sokol, H., Dor\u00e9, J., Corthier, G., and Furet, J.P. (2009). Firmicutes\/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol., 9.","DOI":"10.1186\/1471-2180-9-123"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.micpath.2017.08.038","article-title":"Comparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals","volume":"111","author":"Sedighi","year":"2017","journal-title":"Microb. Pathog."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Magne, F., Gotteland, M., Gauthier, L., Zazueta, A., Pesoa, S., Navarrete, P., and Balamurugan, R. (2020). Firmicutes\/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients?. Nutrients, 12.","DOI":"10.3390\/nu12051474"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Grigor\u2019eva, I.N. (2020). Gallstone Disease, Obesity and the Firmicutes\/Bacteroidetes Ratio as a Possible Biomarker of Gut Dysbiosis. J. Pers. Med., 11.","DOI":"10.3390\/jpm11010013"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"873048","DOI":"10.3389\/fcimb.2022.873048","article-title":"Comparison of gut microbiota in male MAFLD patients with varying liver stiffness","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"969757","DOI":"10.3389\/fmicb.2022.969757","article-title":"Integrative analysis of gut microbiota and fecal metabolites in metabolic associated fatty liver disease patients","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Oh, J.H., Lee, J.H., Cho, M.S., Kim, H., Chun, J., Lee, J.H., Yoon, Y., and Kang, W. (2021). Characterization of Gut Microbiome in Korean Patients with Metabolic Associated Fatty Liver Disease. Nutrients, 13.","DOI":"10.3390\/nu13031013"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Yang, Q., Zhang, L., Li, Q., Gu, M., Qu, Q., Yang, X., Yi, Q., Gu, K., Kuang, L., and Hao, M. (2022). Characterization of microbiome and metabolite analyses in patients with metabolic associated fatty liver disease and type II diabetes mellitus. BMC Microbiol., 22.","DOI":"10.1186\/s12866-022-02526-w"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Dorofeyev, A., Rudenko, M., and Cheverda, T. (2022). State of The Gut Microbiota in Patients with Metabolic-Associated Fatty Liver Disease with Type 2 Diabetes Mellitus. Proc. Shevchenko Sci. Soc. Med. Sci., 69.","DOI":"10.25040\/ntsh2022.02.12"},{"key":"ref_27","first-page":"339","article-title":"Gut microbiota and non-alcoholic fatty liver disease","volume":"67","author":"Abenavoli","year":"2021","journal-title":"Minerva Gastroenterol. (Torino)"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Abenavoli, L., Giubilei, L., Procopio, A.C., Spagnuolo, R., Luzza, F., Boccuto, L., and Scarpellini, E. (2022). Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex Interplay. Nutrients, 14.","DOI":"10.3390\/nu14245323"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Li, H., Guo, M., An, Z., Meng, J., Jiang, J., Song, J., and Wu, W. (2020). Prevalence and Risk Factors of Metabolic Associated Fatty Liver Disease in Xinxiang, China. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17061818"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4161\/gmic.23362","article-title":"The gut microbiota and mucosal homeostasis: Colonized at birth or at adulthood, does it matter?","volume":"4","author":"Hooiveld","year":"2013","journal-title":"Gut Microbes"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fimmu.2018.00005","article-title":"Nutrients Mediate Intestinal Bacteria-Mucosal Immune Crosstalk","volume":"9","author":"Ma","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.jcmgh.2021.02.007","article-title":"Regulation of Intestinal Barrier Function by Microbial Metabolites","volume":"11","author":"Ghosh","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"17317","DOI":"10.1074\/jbc.RA118.003908","article-title":"The scaffolding protein ZO-1 coordinates actomyosin and epithelial apical specializations in vitro and in vivo","volume":"293","author":"Odenwald","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1053\/j.gastro.2016.06.022","article-title":"Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol","volume":"151","author":"Rahman","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e01438-14","DOI":"10.1128\/mBio.01438-14","article-title":"Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids","volume":"5","author":"Lukovac","year":"2014","journal-title":"mBio"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/gutjnl-2014-308778","article-title":"Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: Relationship with gut microbiome richness and ecology","volume":"65","author":"Dao","year":"2016","journal-title":"Gut"},{"key":"ref_37","first-page":"242","article-title":"Akkermansia muciniphila as a novel powerful bacterial player in the treatment of metabolic disorders","volume":"47","author":"Kobyliak","year":"2022","journal-title":"Minerva Endocrinol. (Torino)"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1136\/gutjnl-2019-318427","article-title":"Leaky gut: Mechanisms, measurement and clinical implications in humans","volume":"68","author":"Camilleri","year":"2019","journal-title":"Gut"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1152\/ajpgi.00098.2016","article-title":"Gastrointestinal and hepatic mechanisms limiting entry and dissemination of lipopolysaccharide into the systemic circulation","volume":"311","author":"Guerville","year":"2016","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrgastro.2010.172","article-title":"The role of the gut microbiota in nonalcoholic fatty liver disease","volume":"7","author":"Quigley","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Abenavoli, L., Scarpellini, E., Colica, C., Boccuto, L., Salehi, B., Sharifi-Rad, J., Aiello, V., Romano, B., De Lorenzo, A., and Izzo, A.A. (2019). Gut Microbiota and Obesity: A Role for Probiotics. Nutrients, 11.","DOI":"10.3390\/nu11112690"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Portincasa, P., Bonfrate, L., Vacca, M., De Angelis, M., Farella, I., Lanza, E., Khalil, M., Wang, D.Q., Sperandio, M., and Di Ciaula, A. (2022). Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031105"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s42255-018-0017-4","article-title":"Microbial regulation of organismal energy homeostasis","volume":"1","author":"Cani","year":"2019","journal-title":"Nat. Metab."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/ijo.2014.46","article-title":"Evidence for greater production of colonic short-chain fatty acids in overweight than lean humans","volume":"38","author":"Fernandes","year":"2014","journal-title":"Int. J. Obes."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s40168-021-01093-y","article-title":"From gut microbiota to host appetite: Gut microbiota-derived metabolites as key regulators","volume":"9","author":"Han","year":"2021","journal-title":"Microbiome"},{"key":"ref_46","first-page":"21","article-title":"Gene Expression and the Control of Food Intake by Hypothalamic POMC\/CART Neurons","volume":"3","author":"Hill","year":"2010","journal-title":"Open Neuroendocrinol. J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/jb\/mvr134","article-title":"Structure, regulation and function of ghrelin","volume":"151","author":"Sato","year":"2012","journal-title":"J. Biochem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1079\/BJN20061787","article-title":"Ghrelin: A hormone regulating food intake and energy homeostasis","volume":"96","author":"Aguilera","year":"2006","journal-title":"Br. J. Nutr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1042\/BJ20082353","article-title":"Structure of human insulin-like peptide 5 and characterization of conserved hydrogen bonds and electrostatic interactions within the relaxin framework","volume":"419","author":"Hossain","year":"2009","journal-title":"Biochem. J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/bph.13522","article-title":"Signal transduction pathways activated by insulin-like peptide 5 at the relaxin family peptide RXFP4 receptor","volume":"174","author":"Ang","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"11133","DOI":"10.1073\/pnas.1411413111","article-title":"Insulin-like peptide 5 is an orexigenic gastrointestinal hormone","volume":"111","author":"Grosse","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"170116","DOI":"10.1016\/j.peptides.2019.170116","article-title":"Insulin-like peptide 5 fails to improve metabolism or body weight in obese mice","volume":"120","author":"Zaykov","year":"2019","journal-title":"Peptides"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Kim, K.N., Yao, Y., and Ju, S.Y. (2019). Short Chain Fatty Acids and Fecal Microbiota Abundance in Humans with Obesity: A Systematic Review and Meta-Analysis. Nutrients, 11.","DOI":"10.3390\/nu11102512"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"598093","DOI":"10.3389\/fcimb.2021.598093","article-title":"Taxonomic Characterization and Short-Chain Fatty Acids Production of the Obese Microbiota","volume":"11","author":"Requena","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_55","first-page":"e12178","article-title":"Association of Leptin With Obesity and Insulin Resistance","volume":"12","author":"Kumar","year":"2020","journal-title":"Cureus"},{"key":"ref_56","first-page":"27","article-title":"Correlation between Serum Leptin Levels, Body Mass Index and Obesity in Omanis","volume":"6","author":"Alnaqdy","year":"2006","journal-title":"Sultan Qaboos Univ. Med. J."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1038\/s41598-022-06636-3","article-title":"Circulating acyl and des-acyl ghrelin levels in obese adults: A systematic review and meta-analysis","volume":"12","author":"Wang","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11154-020-09621-1","article-title":"Lean NAFLD: An underrecognized and challenging disorder in medicine","volume":"22","author":"Maier","year":"2021","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12933-019-0870-9","article-title":"Inflammatory cytokines in type 2 diabetes mellitus as facilitators of hypercoagulation and abnormal clot formation","volume":"18","author":"Randeria","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature13564","article-title":"Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes","volume":"514","author":"Wang","year":"2014","journal-title":"Nature"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1038\/s41467-019-09884-6","article-title":"Bacteroides fragilis polysaccharide A induces IL-10 secreting B and T cells that prevent viral encephalitis","volume":"10","author":"Ramakrishna","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"155841","DOI":"10.1016\/j.cyto.2022.155841","article-title":"Interleukin-6 absence triggers intestinal microbiota dysbiosis and mucosal immunity in mice","volume":"153","author":"Wu","year":"2022","journal-title":"Cytokine"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e00213","DOI":"10.1128\/mSystems.00213-17","article-title":"Interleukin 1\u03b1-Deficient Mice Have an Altered Gut Microbiota Leading to Protection from Dextran Sodium Sulfate-Induced Colitis","volume":"3","author":"Nunberg","year":"2018","journal-title":"mSystems"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13099-021-00446-0","article-title":"Gut microbiota influence in type 2 diabetes mellitus (T2DM)","volume":"13","author":"Cunningham","year":"2021","journal-title":"Gut Pathog."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"101067","DOI":"10.1016\/j.molmet.2020.101067","article-title":"Gut microbiota impairs insulin clearance in obese mice","volume":"42","author":"Foley","year":"2020","journal-title":"Mol. Metab."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.2147\/DMSO.S256864","article-title":"Insulin Resistance is Associated with Gut Permeability Without the Direct Influence of Obesity in Young Adults","volume":"13","author":"Mkumbuzi","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Sakurai, Y., Kubota, N., Yamauchi, T., and Kadowaki, T. (2021). Role of Insulin Resistance in MAFLD. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22084156"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Dongiovanni, P., Meroni, M., Longo, M., Fargion, S., and Fracanzani, A.L. (2018). miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19123966"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1038\/s41598-017-04991-0","article-title":"MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals","volume":"7","author":"Donati","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"9282557","DOI":"10.1155\/2022\/9282557","article-title":"Single Nucleotide Polymorphism of Genes Associated with Metabolic Fatty Liver Disease","volume":"2022","author":"Mu","year":"2022","journal-title":"J. Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e24626","DOI":"10.1002\/jcla.24626","article-title":"Genetic variants associated with metabolic dysfunction-associated fatty liver disease in western China","volume":"36","author":"Liao","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"22962","DOI":"10.3402\/jom.v6.22962","article-title":"Genetic dysbiosis: The role of microbial insults in chronic inflammatory diseases","volume":"6","author":"Nibali","year":"2014","journal-title":"J. Oral. Microbiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","article-title":"Pattern recognition receptors in health and diseases","volume":"6","author":"Li","year":"2021","journal-title":"Signal. Transduct. Target. Ther."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Sobhani, I., Tap, J., Roudot-Thoraval, F., Roperch, J.P., Letulle, S., Langella, P., Corthier, G., Tran Van Nhieu, J., and Furet, J.P. (2011). Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016393"},{"key":"ref_75","first-page":"1","article-title":"Eubiosis and dysbiosis: The two sides of the microbiota","volume":"39","author":"Iebba","year":"2016","journal-title":"New. Microbiol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Leeming, E.R., Johnson, A.J., Spector, T.D., and Le Roy, C.I. (2019). Effect of Diet on the Gut Microbiota: Rethinking Intervention Duration. Nutrients, 11.","DOI":"10.3390\/nu11122862"},{"key":"ref_77","first-page":"9","article-title":"What should we advise MAFLD patients to eat and drink?","volume":"1","author":"Machado","year":"2021","journal-title":"Metab. Target Organ. Damage"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"419","DOI":"10.21037\/hbsn-21-562","article-title":"The role of diet in the management of MAFLD-why does a new disease require a novel, individualized approach?","volume":"11","author":"Kurylowicz","year":"2022","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Italian Association for the Study of the Liver (AISF) (2017). AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions. Dig. Liver Dis., 49, 471\u2013483.","DOI":"10.1016\/j.dld.2017.01.147"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Abenavoli, L., Boccuto, L., Federico, A., Dallio, M., Loguercio, C., Di Renzo, L., and De Lorenzo, A. (2019). Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way. Int. J. Environ. Res. Public Health, 16.","DOI":"10.3390\/ijerph16173011"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"D\u2019Innocenzo, S., Biagi, C., and Lanari, M. (2019). Obesity and the Mediterranean Diet: A Review of Evidence of the Role and Sustainability of the Mediterranean Diet. Nutrients, 11.","DOI":"10.3390\/nu11061306"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Mart\u00edn-Pel\u00e1ez, S., Fito, M., and Castaner, O. (2020). Mediterranean Diet Effects on Type 2 Diabetes Prevention, Disease Progression, and Related Mechanisms. A Review. Nutrients, 12.","DOI":"10.3390\/nu12082236"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/01635581.2013.795599","article-title":"Dietary influence on MAPK-signaling pathways and risk of colon and rectal cancer","volume":"65","author":"Slattery","year":"2013","journal-title":"Nutr. Cancer"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1080\/10408398.2019.1661827","article-title":"Targeting NF-\u03baB signaling pathway in cancer by dietary polyphenols","volume":"60","author":"Khan","year":"2020","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Gugliandolo, E., Cordaro, M., Siracusa, R., D\u2019Amico, R., Peritore, A.F., Genovese, T., Impellizzeri, D., Paola, R.D., Crupi, R., and Cuzzocrea, S. (2020). Novel Combination of COX-2 Inhibitor and Antioxidant Therapy for Modulating Oxidative Stress Associated with Intestinal Ischemic Reperfusion Injury and Endotoxemia. Antioxidants, 9.","DOI":"10.3390\/antiox9100930"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Deledda, A., Annunziata, G., Tenore, G.C., Palmas, V., Manzin, A., and Velluzzi, F. (2021). Diet-Derived Antioxidants and Their Role in Inflammation, Obesity and Gut Microbiota Modulation. Antioxidants, 10.","DOI":"10.3390\/antiox10050708"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Zunica, E.R.M., Heintz, E.C., Axelrod, C.L., and Kirwan, J.P. (2022). Obesity Management in the Primary Prevention of Hepatocellular Carcinoma. Cancers, 14.","DOI":"10.3390\/cancers14164051"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","article-title":"Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics","volume":"14","author":"Gibson","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41575-021-00440-6","article-title":"The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics","volume":"18","author":"Salminen","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"41","DOI":"10.15403\/jgld.2014.1121.271.kby","article-title":"A Multi-strain Probiotic Reduces the Fatty Liver Index, Cytokines and Aminotransferase levels in NAFLD Patients: Evidence from a Randomized Clinical Trial","volume":"27","author":"Kobyliak","year":"2018","journal-title":"J. Gastrointest. Liver Dis."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"418","DOI":"10.23736\/S0026-4806.18.05845-7","article-title":"Beneficial effects of probiotic combination with omega-3 fatty acids in NAFLD: A randomized clinical study","volume":"109","author":"Kobyliak","year":"2018","journal-title":"Minerva Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5604\/01.3001.0010.7547","article-title":"Efficacy of Probiotics and Smectite in Rats with Non-Alcoholic Fatty Liver Disease","volume":"17","author":"Kobyliak","year":"2018","journal-title":"Ann. Hepatol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Nguyen, H.T., Gu, M., Werlinger, P., Cho, J.H., Cheng, J., and Suh, J.W. (2022). Lactobacillus sakei MJM60958 as a Potential Probiotic Alleviated Non-Alcoholic Fatty Liver Disease in Mice Fed a High-Fat Diet by Modulating Lipid Metabolism, Inflammation, and Gut Microbiota. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232113436"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1014670","DOI":"10.3389\/fendo.2022.1014670","article-title":"Probiotics for the improvement of metabolic profiles in patients with metabolic-associated fatty liver disease: A systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"11240","DOI":"10.12998\/wjcc.v10.i31.11240","article-title":"Intestinal microbiota in the treatment of metabolically associated fatty liver disease","volume":"10","author":"Wang","year":"2022","journal-title":"World J. Clin. Cases"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Lanthier, N., and Delzenne, N. (2022). Targeting the Gut Microbiome to Treat Metabolic Dysfunction-Associated Fatty Liver Disease: Ready for Prime Time?. Cells, 11.","DOI":"10.3390\/cells11172718"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/3\/594\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:57:15Z","timestamp":1760122635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/3\/594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":97,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["medicina59030594"],"URL":"https:\/\/doi.org\/10.3390\/medicina59030594","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,17]]}}}